XPAT

Serial Number 88431972
Registration 6212039
700

Registration Progress

Application Filed
May 15, 2019
Under Examination
Mar 17, 2020
Approved for Publication
Jan 21, 2020
Published for Opposition
Jan 21, 2020
Registered
Dec 1, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20201201)
Due: Dec 01, 2026 310 days

Trademark Image

XPAT

Basic Information

Serial Number
88431972
Registration Number
6212039
Filing Date
May 15, 2019
Registration Date
December 1, 2020
Published for Opposition
January 21, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 1, 2020
Registration
Registered
Classes
001 005

Rights Holder

Amunix Pharmaceuticals, Inc.

03
Address
2 Tower PL, #1100
South San Francisco, CA 940801826

Ownership History

Amunix Pharmaceuticals, Inc.

Original Applicant
03
Mountain View, CA

Amunix Pharmaceuticals, Inc.

Owner at Publication
03
South San Francisco, CA

Amunix Pharmaceuticals, Inc.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
Aaron D. Hendelman

USPTO Deadlines

Next Deadline
310 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20201201)
Due Date
December 01, 2026
Grace Period Ends
June 01, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Dec 1, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Dec 1, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 27, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 26, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 2, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 29, 2020 IUAF S USE AMENDMENT FILED Loading...
Sep 29, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 24, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 23, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 15, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 22, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 15, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 17, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 21, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 21, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 1, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 19, 2019 ALIE A ASSIGNED TO LIE Loading...
Dec 17, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 16, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 16, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 16, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 5, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 5, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 5, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 31, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
May 31, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 18, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemicals used in the manufacture of pharmaceuticals; reagents, enzymes, and nucleotides for scientific or medical research; protein polymeric intermediates for use in the manufacture of pharmaceutical preparations; biomedical compounds, namely, peptides, peptidomimetics, and protein polymeric intermediates used in the manufacture of pharmaceutical preparations
First Use Anywhere: Mar 11, 2019
First Use in Commerce: Aug 12, 2020
Class 005
Pharmaceutical preparations for the treatment of cancerous and viral diseases; pharmaceutical preparations for use in the field of oncology; medical diagnostic reagents; reagents for use in testing proteins for medical and diagnostic purposes
First Use Anywhere: Mar 11, 2019
First Use in Commerce: Aug 12, 2020

Additional Information

Pseudo Mark
X PAT

Classification

International Classes
001 005